2022-2023 Meredith A. Cowden Foundation Annual Sponsor
Become a Sponsor
Please contact Lyn Haselton, symposium manager by email at lynhaselton@cowdenfoundation.org with questions.
GvHD Symposium
2022-2023 GvHD Sponsors
ABOUT THE GvHD NATIONAL SYMPOSIUM
This unique conference focuses on cutting-edge research and new treatments. Our symposia have two tracks: one designed for physicians and other health care professionals, and one for bone marrow transplant (BMT) survivors, their families, and their caregivers.
The Meredith A. Cowden Foundation in collaboration with the Case Comprehensive Cancer Center, University Hospitals Seidman Cancer Center, and Cleveland Clinic Taussig Cancer Institute created the GvHD National Symposium in 2010 to raise awareness about Graft vs. Host Disease (GvHD), to promote research to further our understanding of its cause, and to review cutting edge approaches to prevention and treatment.
Over 1,700 people have attended our events, which have provided an opportunity for attendees to interact with some of the world’s leading authorities on GvHD, a complication that affects over 60% of bone marrow transplant patients. Our past symposiums have served as invaluable experiences to learn, network, and exchange ideas with each other.
A Unique Conference
Innovative And Life-Changing Research Presentations For Physicians, Health Care Professionals, And Survivors
Our Partners
The Meredith A. Cowden Foundation is proud to have provided funding for research, primarily concerning Graft vs. Host Disease (GvHD). GvHD is the main contributor to mortality following bone marrow transplantations in patients with leukemia.
Cleveland Clinic Cancer Center
Cleveland Clinic Cancer Center
9500 Euclid Avenue, Cleveland, Ohio 44195
800.223.2273
https://my.clevelandclinic.org/departments/cancer
University Hospitals Seidman Cancer Center
One of only 41 Comprehensive Cancer Centers in the country designated by the National Cancer Institute (NCI), Seidman can offer cutting-edge treatments earlier than most other cancer centers. Our affiliation with Case Western Reserve University provides ongoing studies aimed at cancer treatment and prevention.
Patients receive skilled care through our multidisciplinary team approach. Experts in surgery, medical oncology, radiation therapy, pathology, nursing, social work, and psychology work together to create a personalized treatment plan that meets physical, emotional and spiritual needs.
Recognized by U.S. News and World Report as one of the top hospitals for cancer care in the country, the mission of Seidman Cancer Center is simple: to cure cancer
University Hospitals Seidman Cancer Center at UH Cleveland Medical Center
11100 Euclid Ave
Cleveland, OH 44106
216-844-3951
http://www.uhhospitals.org/seidman
Case Comprehensive Cancer Center
Located in Cleveland, Ohio, the Case CCC is an NCI designated cancer center and serves the cancer research and clinical needs of an urban manufacturing and rural agricultural region containing 3.8 million people in Northern Ohio
Campus Location:
Wolstein Research Building, Suite 1422
2103 Cornell Road
Cleveland, OH 44106
https://case.edu/cancer/
UPMC Hillman Cancer Center
We are the region’s only comprehensive cancer center designated by the National Cancer Institute. And with more than 60 UPMC Hillman Cancer Center locations, you won’t have to travel far to receive world-class treatments backed by best practices and leading-edge protocols.
Learn more about who we are and how we can help you.
UPMC Hillman Cancer Center
5115 Centre Ave., Fourth Floor
Pittsburgh, PA 15232
412-864-6600
http://hillman.upmc.com/
BMT Infonet
Founded in 1990, BMT InfoNet has pioneered a vast array of services to help transplant patients make critical decisions throughout their transplant journey.
BMT InfoNet
1548 Old Skokie Road, Suite 1
Highland Park, IL 60035
Toll Free: (888) 597-7674
www.bmtinfonet.org
nbmtLINK
- Survivorship Resources
- Original Publications
- Informative Webcasts
- Emmy Award-winning Video
- Online Resource Library
- Peer Support on Call
- Telephone Education/Support Groups
20411 West 12 Mile Rd., Suite 108
Southfield, MI 48076
(800) 546-5268 (1-800-LINK-BMT)
E-mail: info@nbmtlink.org
www.nbmtlink.org
GvHD Symposium
Planning Commitee
Steven Z. Pavletic, MD, MS
National Cancer Institute / NIH
Dr. Pavletic received his M.D. from the University of Zagreb School of Medicine in Croatia in 1979. In 1992, he completed a clinical fellowship in bone marrow transplantation at the Fred Hutchinson Cancer Research Center and University of Washington Medical School in Seattle, WA. In 1995, he completed his internal medicine residency at the University of Nebraska Medical Center (UNMC) in Omaha, NE, and completed his hematology and oncology fellowship in June 1997. Until October 2002, Dr. Pavletic served as the director of the Allogeneic Stem Cell Transplantation Program at UNMC. In 2002, Dr. Pavletic received an appointment at the National Cancer Institute (NCI) and an adjunct appointment at the National Institute for Arthritis and Musculoskeletal and Skin Diseases at NIH. Currently, he is the head of the Graft-versus-Host and Autoimmunity Unit in the Experimental Transplantation and Immunology Branch. In October 2006, Dr. Pavletic received the NCI Director’s award for his achievements in developing national and international consensus guidelines for clinical trials in chronic GVHD.
Matt Kalaycio, MD, FACP
Cleveland Clinic
Dr. Kalaycio has been published in numerous scientific publications including Bone Marrow Transplantation, Journal of Clinical Oncology, and Leukemia. He serves on the editorial board of Biology of Blood and Marrow Transplantation. He also is the editor of a book on leukemia and co-editor of a book on clinical malignant hematology. His research interests focus on testing new treatments for leukemia.
Dr. Kalaycio received his degree from West Virginia University School of Medicine in Morgantown. He completed his residency in internal medicine at Mercy Hospital of Pittsburgh and fellowships in hematology and medical oncology and bone marrow transplantation at Cleveland Clinic.
Kenneth R. Cooke, MD
Johns Hopkins Kimmel Cancer Center
A nationally recognized transplantation immunology expert, Dr. Cooke focuses primarily on new strategies to prevent and treat graft-vs-host disease and lung complications following blood and bone marrow transplantation. His research efforts have been recognized by the Leukemia and Lymphoma Society and the American Society of Clinical Investigation. In addition to his younger patients, Dr. Cooke also cares for adolescents and young adults.
Marcos, de Lima, MD
The Ohio State University Comprehensive Cancer Center
Dr. Marcos de Lima is Professor of Medicine, Ohio State University, and Director of Blood and Marrow Transplant and Cellular Therapy programs at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute. He has extensive experience developing and conducting clinical trials in the context of hematopoietic stem cell transplantation for myeloid malignancies. His research focus on strategies to prevent leukemia relapse after transplant, and the development of novel translational cellular therapy approaches to treating blood cancers.
Hien Liu, MD
Moffitt Cancer Center
Annie, Im, MD
UPMC Hillman Cancer Center
Dr. Im is board-certified in internal medicine, hematology, and medical oncology. She received her medical degree from SUNY Stony Brook School of Medicine in Stony Brook, N.Y. Dr. Im completed both her residency in internal medicine and her hematology/oncology fellowship at UPMC.
Dr. Im is a member of the American Society of Clinical Oncology, the American Society of Hematology, and the American Society of Blood and Marrow Transplantation.
Betty Hamilton, MD
Cleveland Clinic Lerner College of Medicine